Investing in Biotech from Horizon 3 Biotech

By Matt McNamara

Horizon 3 is a biotech fund which has been formed to help investors to have a real impact on a range of global health challenges through new bio technologies, aiming to de-risk the investment risks in... more

Download on the App Store

Download on the App Store

Get it on Google Play

FAQs about Investing in Biotech from Horizon 3 Biotech:

How many episodes does Investing in Biotech from Horizon 3 Biotech have?

The podcast currently has 17 episodes available.

Investing in Biotech from Horizon 3 Biotech episodes:

February 10, 2022 Investing in Biotech
Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode, Matt is joined by Jackie Fairley - CEO at Starpharmas & Scott Power - Investment Analyst at Morgans & Horizon 3 Biotech Investment Community Member.
...more
35min
December 22, 2021 Investing in Biotech
Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode, Matt is joined by John McCutcheon - President & CEO at President and CEO at EBR Systems & Elyse Shapiro - Healthcare Analyst at from Canaccord Genuity.
...more
32min
November 08, 2021 Investing in Biotech
Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode, Matt is joined by Dr Megan Baldwi - CEO and Managing Director at Opthea Limited & Daniel Sharp from Canaccord Genuity, one of the most experienced biotech fundraisers in the Australian Market.
...more
43min
October 26, 2021 Investing in Biotech
Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode Matt is joined by Amir Zalcenstein - Managing Director at CNJ Ventures & Leslie Chong - Chief Executive Officer and Managing Director at Imugene Limited.
...more
36min
September 17, 2021 BioBullets: The Great Dispersion
Mike and Ben talk about Scott Galloway's theory of the Great Dispersion - the impact of COVID on business models like direct-to-consumer and how far they're spreading
...more
14min
September 13, 2021 Investing in Biotech
Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara. In this episode Matt is joined by Michael Woods of Newburyport Partners, Dr John Melki Director & CEO at Genetic Signatures & Dr Paul Gavin - CEO of Avecho Biotechnologies.
...more
38min
August 13, 2021 Investing in Biotech
Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Scott Power of Morgans and Jon Pilcher, CEO of Neuren Pharmaceuticals.
...more
28min
August 13, 2021 BioBullets: The Aduhelm FDA approval controversy
This podcast accompanies Horizon 3 Biotech's BioBullets email for the 13th August 2021
...more
11min
July 22, 2021 Investing in Biotech
Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Dr Deborah Rathjen, CEO of Carina Biotech and Simon Davidson, Partner at Lander & Rogers
...more
38min
July 22, 2021 Investing in Biotech
Hosted by Horizon 3 Biotech Chief Investment Officer Matt McNamara In this episode Matt will be joined by Dirk van Dissel of Candour Advisory and Chris Baldwin, Deputy CEO and Chief Commercial Officer of Exopharm.
...more
35min

FAQs about Investing in Biotech from Horizon 3 Biotech:

How many episodes does Investing in Biotech from Horizon 3 Biotech have?

The podcast currently has 17 episodes available.